TrueBlue (TBI) Q3 FY2025 Summary: Operational Efficiency Gains Offset by Integration Costs and Future Impairment Risk
Financial Performance (Q3 & 9 Months Ended 9/28/2025) Total Q3 Revenue increased 12.8% to $431.3 million, driven by demand and the HSP acquisition, though Gross Profit Margin contracted significantly to 22.7% due to unfavorable mix shifts. Q3 Net Loss narrowed substantially to ($1.9 million) from ($7.6 million) YoY, with Diluted EPS improving to ($0.06) from ($0.26). Year-to-date, the Net Loss drastically reduced to ($16.4 million) from ($114.0 million), primari
...